Long-term remission in multiple myeloma—a blood cancer once considered incurable—is finally becoming a reality. A single ...

Lynozyfic (linvoseltamab-gcpt) is a prescription injection medicine for people with a type of blood cancer called multiple myeloma, whose cancer has come back (relapsed) or worsened (refractory) after ...

Information on the disease and treatments, assistance with insurance, and transportation are among the types of support needed by patients with multiple myeloma to improve outcomes and overall burden.

The U.S. Food and Drug Administration (FDA) has updated the safety labeling for Carvykti, the multiple myeloma therapy ...

Iberdomide combined with standard therapies showed a statistically significant improvement in minimal residual disease (MRD) negativity rates, compared with the control arm, in patients with relapsed ...

How Does Talvey Work for Multiple Myeloma? Talvey is a special type of molecule that can attach to two different types of cells. This is called a bispecific antibody. It attaches to GPRC5D proteins on ...

A combination of genetic tests for a "very complex" blood cancer could accurately predict if the disease is likely to return ...

Scientists discovered that inhibiting the enzyme STK17B forces multiple myeloma cells into iron-driven death and makes ...

The FDA adds a new boxed warning for immune effector cell-associated enterocolitis with Carvykti, but says the overall ...